Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Blood
|
July 3, 2025
HbSC gets its mouse model 75 years after discovery
Eduard J van Beers
Therapeutic Advances in Hematology
|
January 6, 2022
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
Hanny Al-Samkari, Eduard J van Beers
Clinical Hemorheology and Microcirculation
|
April 5, 2018
Oxidative stress in sickle cell disease; more than a DAMP squib
Eduard J van Beers, Richard van Wijk
Diabetes
|
June 29, 2007
Comment on: Kretowski et al. (2007) Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis: Diabetes 56:863-871
Eduard J van Beers, Marijn C Meuwese
American Journal of Hematology
|
September 22, 2022
A reply to Moris et al
Annelies J van Vuren, Eduard J van Beers
The New England Journal of Medicine
|
June 29, 2022
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
Hanny Al-Samkari, Vanessa Beynon, Eduard J van Beers
Critical Care (London, England)
|
February 22, 2011
Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report
Eduard J van Beers, Jan Stam, Walter M van den Bergh
American Journal of Hematology
|
December 24, 2009
Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity"
Eduard J Van Beers, Bart J Biemond, John-John B Schnog, et al.
Lancet (London, England)
|
March 15, 2026
Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential
Thomas Doeven, Andreas Glenthøj, Rachael F Grace, et al.
Microvascular Research
|
April 22, 2008
Normal sublingual microcirculation during painful crisis in sickle cell disease
Eduard J van Beers, Peter T Goedhart, Michiel Unger, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Blood
|
July 3, 2025
HbSC gets its mouse model 75 years after discovery
Eduard J van Beers
Therapeutic Advances in Hematology
|
January 6, 2022
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
Hanny Al-Samkari, Eduard J van Beers
Clinical Hemorheology and Microcirculation
|
April 5, 2018
Oxidative stress in sickle cell disease; more than a DAMP squib
Eduard J van Beers, Richard van Wijk
Diabetes
|
June 29, 2007
Comment on: Kretowski et al. (2007) Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis: Diabetes 56:863-871
Eduard J van Beers, Marijn C Meuwese
American Journal of Hematology
|
September 22, 2022
A reply to Moris et al
Annelies J van Vuren, Eduard J van Beers
The New England Journal of Medicine
|
June 29, 2022
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
Hanny Al-Samkari, Vanessa Beynon, Eduard J van Beers
Critical Care (London, England)
|
February 22, 2011
Licorice consumption as a cause of posterior reversible encephalopathy syndrome: a case report
Eduard J van Beers, Jan Stam, Walter M van den Bergh
American Journal of Hematology
|
December 24, 2009
Letter in response to: "Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity"
Eduard J Van Beers, Bart J Biemond, John-John B Schnog, et al.
Lancet (London, England)
|
March 15, 2026
Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential
Thomas Doeven, Andreas Glenthøj, Rachael F Grace, et al.
Microvascular Research
|
April 22, 2008
Normal sublingual microcirculation during painful crisis in sickle cell disease
Eduard J van Beers, Peter T Goedhart, Michiel Unger, et al.
Page
of 10